Targeted Medical Pharma (TMP)

Targeted Medical Pharma files for $118 million IPO

Targeted Medical Pharma, a specialty pharmaceutical company that sells medical food products in the US, filed on Monday with the SEC to raise up to $118 million in an initial public offering. The Los Angeles, CA-based company, which was founded in 1996 and booked $17 million in sales for the 12 months ended September 30, 2010, plans to list on the NASDAQ under the symbol TMP. Sunrise Securities Corp. is the lead underwriter on the deal, for which priing terms and timing were not disclosed.